While the body produces GLP-1 naturally, individuals with type 2 diabetes or obesity may have impaired GLP-1 responses, which makes it harder for them to control blood sugar and manage their weight
Overdose Considerations Researchers have conducted limited studies on GLP-1 analog overdoses
At first glance, activating the glucagon receptor seems counterproductive for a diabetes or weight loss medication
In peptide research, "signal peptide" colloquially refers to small peptides that trigger specific cellular signaling cascades
Rybelsus is the brand name for oral semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist used in type 2 diabetes management
Kwon and Park 2015 reported that intra-articular AOD-9604 injections, especially when combined with hyaluronic acid, improved cartilage scores and reduced lameness in a rabbit collagenase-induced osteoarthritis model